4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid

C180H234N20O17 — CID 157477724

About 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid

4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid (PubChem CID 157477724) has the molecular formula C180H234N20O17 and a molecular weight of 2949.97 g/mol. Its IUPAC name is 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid.

Molecular Properties

• Compound Name: 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid
• PubChem CID: 157477724
• Molecular Formula: C180H234N20O17
• Molecular Weight: 2949.97 g/mol
• Exact Mass: 2947.81
• IUPAC Name: 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid
• SMILES: CC(=O)C(C)N1CCC(O)(C(=O)NCCCc2ccc3c(n2)CCCC3)CC1.CC(=O)C(c1ccccc1)N1CCC(C)(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)C(c1ccccc1)N1CCC(O)(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.O=C(O)C(c1ccccc1)N1CC[C@H](C(=O)NCCCc2ccc3c(n2)CCCC3)C1
• InChI: InChI=1S/C28H37N3O2.C27H35N3O3.2C27H34N2O2.C25H31N3O3.C24H30N4O2.C22H33N3O3/c1-21(32)26(22-9-4-3-5-10-22)31-19-16-28(2,17-20-31)25(33)13-7-6-12-24-15-14-23-11-8-18-29-27(23)30-24;1-20(31)25(21-8-3-2-4-9-21)30-18-15-27(33,16-19-30)24(32)12-6-5-11-23-14-13-22-10-7-17-28-26(22)29-23;2*1-20(30)27(22-11-4-2-5-12-22)29-18-23(19-29)26(31)15-7-3-6-13-24-17-16-21-10-8-9-14-25(21)28-24;29-24(26-15-6-10-21-13-12-18-7-4-5-11-22(18)27-21)20-14-16-28(17-20)23(25(30)31)19-8-2-1-3-9-19;1-17(29)23(18-7-3-2-4-8-18)28-15-21(16-28)26-22(30)11-5-10-20-13-12-19-9-6-14-25-24(19)27-20;1-16(17(2)26)25-14-11-22(28,12-15-25)21(27)23-13-5-7-19-10-9-18-6-3-4-8-20(18)24-19/h3-5,9-10,14-15,26H,6-8,11-13,16-20H2,1-2H3,(H,29,30);2-4,8-9,13-14,25,33H,5-7,10-12,15-19H2,1H3,(H,28,29);2*2,4-5,11-12,16-17,23,27H,3,6-10,13-15,18-19H2,1H3;1-3,8-9,12-13,20,23H,4-7,10-11,14-17H2,(H,26,29)(H,30,31);2-4,7-8,12-13,21,23H,5-6,9-11,14-16H2,1H3,(H,25,27)(H,26,30);9-10,16,28H,3-8,11-15H2,1-2H3,(H,23,27)/t;;2*27-;20-,23?;23-;/m..1001./s1
• InChIKey: BVUHILKBXHZJGA-FSVPUGBUSA-N
• XLogP: 26.69
• TPSA: 484.76 Ų
• H-Bond Donors: 9
• H-Bond Acceptors: 33
• Rotatable Bonds: 61
• Heavy Atoms: 217
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2949.97
LogP ≤ 5	26.69
H-Bond Donors ≤ 5	9
H-Bond Acceptors ≤ 10	33

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

The IUPAC name of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid (CID 157477724) is 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid.

What is the SMILES notation for 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

The canonical SMILES for 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid is CC(=O)C(C)N1CCC(O)(C(=O)NCCCc2ccc3c(n2)CCCC3)CC1.CC(=O)C(c1ccccc1)N1CCC(C)(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)C(c1ccccc1)N1CCC(O)(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(C(=O)CCCCCc2ccc3c(n2)CCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.O=C(O)C(c1ccccc1)N1CC[C@H](C(=O)NCCCc2ccc3c(n2)CCCC3)C1.

What is the InChIKey of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

The InChIKey is BVUHILKBXHZJGA-FSVPUGBUSA-N. The full InChI is InChI=1S/C28H37N3O2.C27H35N3O3.2C27H34N2O2.C25H31N3O3.C24H30N4O2.C22H33N3O3/c1-21(32)26(22-9-4-3-5-10-22)31-19-16-28(2,17-20-31)25(33)13-7-6-12-24-15-14-23-11-8-18-29-27(23)30-24;1-20(31)25(21-8-3-2-4-9-21)30-18-15-27(33,16-19-30)24(32)12-6-5-11-23-14-13-22-10-7-17-28-26(22)29-23;2*1-20(30)27(22-11-4-2-5-12-22)29-18-23(19-29)26(31)15-7-3-6-13-24-17-16-21-10-8-9-14-25(21)28-24;29-24(26-15-6-10-21-13-12-18-7-4-5-11-22(18)27-21)20-14-16-28(17-20)23(25(30)31)19-8-2-1-3-9-19;1-17(29)23(18-7-3-2-4-8-18)28-15-21(16-28)26-22(30)11-5-10-20-13-12-19-9-6-14-25-24(19)27-20;1-16(17(2)26)25-14-11-22(28,12-15-25)21(27)23-13-5-7-19-10-9-18-6-3-4-8-20(18)24-19/h3-5,9-10,14-15,26H,6-8,11-13,16-20H2,1-2H3,(H,29,30);2-4,8-9,13-14,25,33H,5-7,10-12,15-19H2,1H3,(H,28,29);2*2,4-5,11-12,16-17,23,27H,3,6-10,13-15,18-19H2,1H3;1-3,8-9,12-13,20,23H,4-7,10-11,14-17H2,(H,26,29)(H,30,31);2-4,7-8,12-13,21,23H,5-6,9-11,14-16H2,1H3,(H,25,27)(H,26,30);9-10,16,28H,3-8,11-15H2,1-2H3,(H,23,27)/t;;2*27-;20-,23?;23-;/m..1001./s1.

What are the key properties of 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid has a molecular weight of 2949.97 g/mol, XLogP of 26.69, 61 rotatable bonds, 9 hydrogen bond donors, and 33 hydrogen bond acceptors.

Where does this data come from?

All data for 4-hydroxy-1-(3-oxobutan-2-yl)-N-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propyl]piperidine-4-carboxamide;1-[4-hydroxy-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[4-methyl-1-(2-oxo-1-phenylpropyl)piperidin-4-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;1-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-6-(5,6,7,8-tetrahydroquinolin-2-yl)hexan-1-one;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydroquinolin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid is sourced from PubChem (CID 157477724), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).